See the DrugPatentWatch profile for Abreva
Abreva, a brand name for docosanol, was owned by GlaxoSmithKline (GSK) in 2016 [1].
Who owns Abreva now?
In 2016, GlaxoSmithKline (GSK) owned the Abreva brand. More recently, as of late 2023 and early 2024, Abreva is a product of Haleon [2]. Haleon was formed in July 2022 as a demerger from GSK, creating a new, independent consumer healthcare company [3].
What is Abreva used for?
Abreva is used to treat cold sores [1]. It is an over-the-counter medication [4].
How does Abreva work?
The active ingredient in Abreva is docosanol 10% cream [1]. Docosanol is believed to work by inhibiting the ability of the herpes simplex virus (HSV) to enter cells and replicate [5]. By blocking viral entry into cells, it aims to shorten the healing time of cold sores [4].
How long does Abreva take to work?
When used as directed, Abreva can shorten the healing time of cold sores [4]. Clinical studies have shown that Abreva can heal cold sores in as few as 4 days [1]. However, it is most effective when applied at the first sign of a tingle, itch, or burn [4].
Where can I buy Abreva?
Abreva is available as an over-the-counter product and can be purchased at most pharmacies and drug stores [4]. It is also available through online retailers [1].
What are the side effects of Abreva?
Common side effects associated with Abreva may include application site reactions such as burning, itching, or redness [1].
Are there alternatives to Abreva for cold sores?
Yes, there are other treatment options for cold sores. These include other topical antiviral creams and prescription medications [6]. Some individuals also use home remedies or alternative therapies, although scientific evidence for their efficacy can vary [7].
When did Abreva become available?
Docosanol was approved by the U.S. Food and Drug Administration (FDA) for the treatment of cold sores in 2000 [8].
Sources:
[1] https://www.abreva.com/
[2] https://www.haleon.com/our-brands/
[3] https://www.reuters.com/business/haleon-becomes-lonely-lonely-after-gsk-demerger-2022-07-18/
[4] https://www.cvs.com/shop/abreva-cream-10-docosanol-prodid-133114
[5] https://www.webmd.com/drugs/2/drug-76476/docosanol-topical/details
[6] https://www.mayoclinic.org/diseases-conditions/cold-sore/diagnosis-treatment/drc-20371023
[7] https://www.medicalnewstoday.com/articles/320290
[8] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients/drug-safety-label-changes-new-safety-information-label-updates-fda